RLN2

RLN2

Target · Peptide hormone

RLN2 Relaxin 2 · Prorelaxin H2

RLN2 (relaxin 2, also known as H2, RLXH2 or prorelaxin H2) is a secreted peptide hormone of the relaxin subfamily within the insulin superfamily. It was first recognised for its role in pregnancy and also acts in the cardiovascular and reproductive systems. Browse Assay Genie's current range of RLN2 research reagents below, or read on for the biology behind the target.

Secreted hormoneInsulin family peptideAnti-fibrotic, cardioprotective roles
185 aa
Protein length
~21 kDa
Molecular weight
9p24.1
Gene locus
Insulin family
Protein family
Target information

What is RLN2 (relaxin 2)?

RLN2 is an ovarian hormone that acts with oestrogen to produce dilatation of the birth canal in many mammals. It may be involved in remodelling of connective tissues during pregnancy, promoting growth of pubic ligaments and ripening of the cervix. The hormone plays a role in both the male and female reproductive systems, and it was initially noted for its role in pregnancy.

The RLN2 gene encodes a member of the relaxin subfamily and the insulin superfamily of peptide hormones, and the protein is secreted. The gene encodes multiple protein isoforms, at least one of which undergoes proteolytic processing. This processing generates relaxin A and B chains, which are linked by disulfide bonds to form the mature peptide hormone. UniProt lists the precursor as prorelaxin H2.

Beyond reproduction, the RLN2 protein has broader roles in the cardiovascular system, including regulation of blood pressure and control of heart rate. Data from animal models indicate that it may have anti-fibrotic and cardioprotective effects, which makes it a point of interest well outside obstetric biology.

Humans have three non-allelic relaxin genes. HGNC places RLN2 in the relaxin family and the neuropeptides group, and records the previous name relaxin 2 (H2). Aliases include H2, RLXH2, bA12D24.1.1 and bA12D24.1.2. RLN1 and RLN3 are the other relaxin family genes with related target pages.

Reproductive biology

RLN2 acts with oestrogen in dilatation of the birth canal and plays a role in the male and female reproductive systems.

Pregnancy and connective tissue

RLN2 may contribute to connective tissue remodelling in pregnancy, including growth of pubic ligaments and ripening of the cervix.

Cardiovascular research

RLN2 is implicated in the regulation of blood pressure and heart rate, and may have cardioprotective effects in animal models.

Fibrosis studies

Animal model data suggest RLN2 may have anti-fibrotic effects, making it relevant to studies of tissue remodelling.

Background

RLN2 frequently asked questions

What does RLN2 do?

RLN2 is a secreted ovarian peptide hormone that acts with oestrogen to dilate the birth canal in many mammals. It may help remodel connective tissue in pregnancy. It also influences blood pressure and heart rate, and may be anti-fibrotic and cardioprotective in animal models.

What are the other names and isoforms of RLN2?

RLN2 is also called relaxin 2, prorelaxin H2, H2 and RLXH2, with the clone-derived aliases bA12D24.1.1 and bA12D24.1.2. The gene encodes multiple isoforms, and at least one is proteolytically processed into disulfide-linked relaxin A and B chains.

How is RLN2 related to other relaxins and the insulin family?

RLN2 belongs to the relaxin subfamily of the insulin superfamily. Humans carry three non-allelic relaxin genes, including RLN1 and RLN3. Like insulin, the mature hormone is built from A and B chains joined by disulfide bonds. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other relaxin family peptide hormones related to RLN2 within the insulin superfamily.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P04090; product specifications from Assay Genie datasheets.

RLN2 Product listing